Human HNSCC: CYP1B1/1A1/1A2 and AHR Gene Polymorphisms

人类 HNSCC:CYP1B1/1A1/1A2 和 AHR 基因多态性

基本信息

  • 批准号:
    7192461
  • 负责人:
  • 金额:
    $ 27.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cytochromes P450 1B1, 1A1 & 1A2 (CYP1B1, CYP1A1, and CYP1A2) are responsible for both detoxifying and metabolically activating innumerable polycyclic aromatic hydrocarbons (PAHs), nitrosamines, and A/-heterocyclics present in combustion processes including cigarette smoke. The PAH- inducible CYP1B1/1A1/1A2 genes are up-regulated by the aromatic hydrocarbon receptor (AHR). Many in vitro, cell culture and animal studies have shown that high CYP1 enzyme levels and AHR high-affinity are correlated with increased genotoxicity caused by PAHs; recent studies with knockout mice, however, show that, whereas high CYP1B1 activity causes metabolic activation, CYP1A1 and CYP1A2 are far more important in detoxication than metabolic activation. Data in humans have been inconclusive, perhaps because many are assuming that all three CYP1 enzymes cause only higher cancer risk. We have a large cohort of head-and-neck squamous-cell carcinoma (HNSCC) patients with a history of one to 40 cigarette pack-years ("highly sensitive," HS) and heavy smokers with >80 pack-years having no cancer ("highly resistant," HR)?strongly suggesting a genetic component. These two extremes will be studied, using the extreme discordant phenotype (EDP) approach. A systematic search (SNP-discovery followed by SNP- typing) for haplotypes of the human,CYP1B1 and AHR genes is now possible; we have completed such a study of the CYP1A1_1A2 locus (39.6 kb) and discovered 85 SNPs, 49 of which were not yet in any database. Our hypothesis is: Specific haplotypes involving one or more of these four genes leading to high CYP1B1 and low CYP1A1/1A2 activities are associated with increased risk of HNSCC cancer in smokers. In the 3 years of this proposed project, we therefore will: [a] carry out whatever SNP-discovery and SNP-typing that still needs to be done, from six major geographically-isolated subgroups; we will collect blood and prepare DMA from 200 HS HNSCC patients and 200 HR non-cancer heavy smokers in our cohort; and [b] examine the association between haplotypes and risk of HNSCC by performing SNP-typing of the CYP1B1, CYP1A1, CYP1A2 and AHR genes in the 200 HS versus the 200 HR individuals. Establishing important phenotype-genotype associations between HNSCC and these four genes would provide the first unequivocal data that humans are similar to laboratory animals regarding cancer and one or more of these genes.
描述(由申请人提供):细胞色素P450 1B 1、1A 1和1A 2(CYP 1B 1、CYP 1A 1和CYP 1A 2)负责解毒和代谢活化燃烧过程(包括香烟烟雾)中存在的无数多环芳烃(PAH)、亚硝胺和N-杂环化合物。PAH诱导型CYP 1B 1/1A 1/1A 2基因受芳烃受体(AHR)上调。许多体外、细胞培养和动物研究表明,高CYP 1酶水平和AHR高亲和力与多环芳烃引起的遗传毒性增加相关;然而,最近对基因敲除小鼠的研究表明,尽管高CYP 1B 1活性导致代谢活化,但CYP 1A 1和CYP 1A 2在解毒方面比代谢活化重要得多。在人类中的数据一直是不确定的,也许是因为许多人假设所有三种CYP 1酶只会导致更高的癌症风险。我们有一个大型队列的头颈部鳞状细胞癌(HNSCC)患者的历史1至40包年(“高度敏感,”HS)和重度吸烟者>80包年没有癌症(“高度耐药,”HR)?强烈暗示了遗传成分将使用极端不一致表型(EDP)方法研究这两个极端。现在可以对人类、CYP 1B 1和AHR基因的单倍型进行系统搜索(SNP发现,然后进行SNP分型);我们已经完成了对CYP1A1_1A2基因座(39.6 kb)的研究,发现了85个SNP,其中49个尚未在任何数据库中。我们的假设是:涉及这四个基因中的一个或多个导致高CYP 1B 1和低CYP 1A 1/1A 2活性的特定单倍型与吸烟者中HNSCC癌症的风险增加相关。因此,在这个拟议项目的3年中,我们将:[a]从六个主要的地理隔离的亚组中进行任何仍然需要进行的SNP发现和SNP分型;我们将从我们队列中的200名HS HNSCC患者和200名HR非癌症重度吸烟者中收集血液并制备DMA;和[B]通过在200名HS与200名HR个体中进行CYP 1B 1、CYP 1A 1、CYP 1A 2和AHR基因的SNP分型来检查单倍型与HNSCC风险之间的关联。在HNSCC和这四个基因之间建立重要的表型-基因型关联将提供第一个明确的数据,即人类在癌症和这些基因中的一个或多个方面与实验室动物相似。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel W. Nebert其他文献

Further Studies on Genetically Mediated Differences in Monooxygenase Activities and Spin State of Cytochrome P<sub>450</sub> Iron from Rabbit, Rat, and Mouse Liver
  • DOI:
    10.1016/s0021-9258(19)43238-9
  • 发表时间:
    1973-11-25
  • 期刊:
  • 影响因子:
  • 作者:
    Daniel W. Nebert;Joseph R. Robinson;Hideo Kon
  • 通讯作者:
    Hideo Kon
Aryl Hydrocarbon Hydroxylase Induction in Mammalian Liver Cell Culture: III. EFFECTS OF VARIOUS SERA, HORMONES, BIOGENIC AMINES, AND OTHER ENDOGENOUS COMPOUNDS ON THE ENZYME ACTIVITY
  • DOI:
    10.1016/s0021-9258(19)44566-3
  • 发表时间:
    1972-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jacques E. Gielen;Daniel W. Nebert
  • 通讯作者:
    Daniel W. Nebert
Measurements of the cytosolic Ah receptor among four strains of Drosophila melanogaster
  • DOI:
    10.1007/bf00295157
  • 发表时间:
    1985-02-01
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Sanford W. Bigelow;Jakob A. Zijlstra;Ekkehart W. Vogel;Daniel W. Nebert
  • 通讯作者:
    Daniel W. Nebert
Genetic Regulation of Aryl Hydrocarbon Hydroxylase Induction: V. SPECIFIC CHANGES IN SPIN STATE OF CYTOCHROME P<sub>450</sub> FROM GENETICALLY RESPONSIVE ANIMALS
  • DOI:
    10.1016/s0021-9258(19)44459-1
  • 发表时间:
    1973-01-10
  • 期刊:
  • 影响因子:
  • 作者:
    Daniel W. Nebert;Hideo Kon
  • 通讯作者:
    Hideo Kon
Genetic Expression of Aryl Hydrocarbon Hydroxylase Induction: EVIDENCE FOR THE INVOLVEMENT OF OTHER GENETIC LOCI
  • DOI:
    10.1016/s0021-9258(20)79896-0
  • 发表时间:
    1974-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Joseph R. Robinson;Noreen Considine;Daniel W. Nebert
  • 通讯作者:
    Daniel W. Nebert

Daniel W. Nebert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel W. Nebert', 18)}}的其他基金

Gene-Environment Interactinos Training Program
基因-环境相互作用培训计划
  • 批准号:
    7464173
  • 财政年份:
    2008
  • 资助金额:
    $ 27.52万
  • 项目类别:
Gene-Environment Interactinos Training Program
基因-环境相互作用培训计划
  • 批准号:
    7647114
  • 财政年份:
    2008
  • 资助金额:
    $ 27.52万
  • 项目类别:
Gene-Environment Interactinos Training Program
基因-环境相互作用培训计划
  • 批准号:
    7885547
  • 财政年份:
    2008
  • 资助金额:
    $ 27.52万
  • 项目类别:
Gene-Environment Interactinos Training Program
基因-环境相互作用培训计划
  • 批准号:
    8103268
  • 财政年份:
    2008
  • 资助金额:
    $ 27.52万
  • 项目类别:
Genetic Differences in PCB-Induced Behavior
PCB 引起的行为的遗传差异
  • 批准号:
    7384892
  • 财政年份:
    2007
  • 资助金额:
    $ 27.52万
  • 项目类别:
Genetic Differences in PCB-Induced Behavior
PCB 引起的行为的遗传差异
  • 批准号:
    7540365
  • 财政年份:
    2007
  • 资助金额:
    $ 27.52万
  • 项目类别:
Human HNSCC: CYP1B1/1A1/1A2 and AHR Gene Polymorphisms
人类 HNSCC:CYP1B1/1A1/1A2 和 AHR 基因多态性
  • 批准号:
    7392834
  • 财政年份:
    2006
  • 资助金额:
    $ 27.52万
  • 项目类别:
Human HNSCC: CYP1B1/1A1/1A2 & AHR Gene Polymorphisms
人类 HNSCC:CYP1B1/1A1/1A2
  • 批准号:
    7092720
  • 财政年份:
    2006
  • 资助金额:
    $ 27.52万
  • 项目类别:
PAHs: Balance of Detoxication vs Metabolic Activation
PAH:解毒与代谢激活的平衡
  • 批准号:
    7188660
  • 财政年份:
    2006
  • 资助金额:
    $ 27.52万
  • 项目类别:
PAHs: Balance of Detoxication vs Metabolic Activation
PAH:解毒与代谢激活的平衡
  • 批准号:
    7354105
  • 财政年份:
    2006
  • 资助金额:
    $ 27.52万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 27.52万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 27.52万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 27.52万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 27.52万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 27.52万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 27.52万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 27.52万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 27.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 27.52万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 27.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了